That was our biggest one day climb I have seen in over a year. That's what happens to an undervalued stock with heavy short interest and lack of investor DD in managements track record of low balling their own guidance. $1.47 ttm EPS...from a PE stand point $15 will become a base going forward into the next week or so. There was no significant dip today which may have likely held back an EOD spike. Today's big gain is a correction for the pas month and a half of decline...unjustified and unexplained decline.
I'm calling .36 eps for Q3. Q4 will be the tough quarter beating YOY. I believe equity has the high end call so far with .50 eps. Quite a few don't want to wander too far from the analyst consensus. That's understandable if you've been neutered/castrated. Happy Wednesday morning market open !!
One EMP would disarm the entire country moving to this highly unreliable technology. The criminals will learn to clone the technology, keeping them safe and convicting the innocent. No self respecting, ready for anything, won't take sqwat from nobody, paranoid, doomsday prepping citizen would consider such technology. It's another angle to disarm the people.
I'm expecting a beat, but if Smith can crank out an EPS of .50/sh, Hammond and other analysts just might make a mess in their underwear. Ruger did take wider expansionary measures that may be attributing to their sales growth. Smith took a different approach making what they had more efficient. Smith will have more of a challenge with sales growth simply due to the month of January when extreme demand occurred after most dealers were running low on inventory. We'll see, but a significant beat is always expected from Smith.
Safety and efficacy are the highlights of Phase 1. That's what sets Bavi apart from Chemo...no toxicity...no cardio damaging elements. Even a slight improvement over docetaxel will be enough to approve it, however, based on the accurate portions of the phase 2 trial, Bavi will be a major improvement. The FDA has to examine the facts from the previous trials A) no toxicity B)efficacy exceeding docetaxel alone...how could they be denied a fast track status?
Any firearm should be treated with respect and should only be fired in approved ranges or into dirt embankments. A wooden wall, brush pile, or tree line is an unacceptable bullet stop. If you are referring to all races and nationalities who live in heavily populated areas, it is not a good idea to allow them to shoot cans with a 22 anywhere but a range. If you are referring to all races and nationalities who live in rural settings with low population and lots of dirt banks/ridgelines, those youth should have every right to shoot as many cans as they want as long as they have been properly counciled, educated, and observed in firearm safety. This is also well know in the Republic as "Parental Responsibility". Libs are clueless on this matter.
Agreed. It was Vangaurd and Acadian as the top two tutes. FMR loaded up. Many believe that the market in general is highly over valued right now. Institutions are looking for bargains and Smith is probably the most fundamentally strong under valued stock on the market. Believe it or not, profits do supercede politics. Tesla cars keep catching on fire. The stock price is way overvalued and is purely speculative right now. When someone's child dies in one of those car fires, Tesla will become a politically incorrect stock. But the big dogs keep hyping it up regardless of how unreliable and dangerous they are. When it tanks, they'll need to find more logical investments...fundamentally sound investments.
I agree with rcorriv. Smith's low ball guidance will not be a miss. Smith always beats when Debney doesn't let the cat out of the bag a week early. As an analyst, I believe it's unethical to change your projection after the CEO releases the data even though it precedes the earnings release. Nobody believes in ethics anymore. I'm expecting a 10-20% beat.
ooooh. Sounds like the shorts are getting desperate. Maybe they are tired of paying margin interest on something they know they will not win on. LOL. I've never seen a short ask someone about the size of ones junk. Artsbest must be into horse meat now that his bum is all wallard out.
Went to the gun shop today. Here's my report: NO 9mm ammo, other common calibers (38 & 40) short supply. M&P: they had 3 M&P 45's in the case. None in 9 or 40. The demand for M&P is clearly outpacing demand for other brands here in VA. Plenty of AR styled rifles to choose from. .223 ammo was available in moderate supply.
I doubt Golden will dump shares until it's fairly valued...low to mid 20's. If Golden dumps, people will criticize him as taking profits after he put Smith in a pinch. If he doesn't, it's a silent way of regaining trust and respect. He was the captain of the ship and he's telling his crew he'll make it right or go down with the ship. He won't take any advantages and will wait until the rest of the crew is safe. He's setting an example with the little bit of power he has left. We like to blame him for mistakes made many moons ago and people will continue to do it if they are given the opportunity. Golden will not give them that satisfaction.
Simple...there citizens won't be able to protect themselves or they will pay much more for revolvers. I'd like to see the microstamping bull work on a steel casing. I have my doubts.
They did diversify and the fence business/security business did not bode well for the company or investors. Diversification only works if it's profitable. Pulling focus away from what is working to something that might work could prove to be a fools bargain. Sounds like more liberal serpent talk moving efforts away from the bread and butter to beans that may or may not grow a giant bean stalk. Facts are Smith is severely undervalued now with a massive back log and growing market share...what makes you think they won't continue to be undervalued selling ammo, condoms, double barrels, sharks with skull mounted laser beams, or chewing tobacco? Focusing on buy backs first, debt reduction second, and dividends third are the most logical steps to improve shareholder value. Smith's track record pertaining to the subject of diversification will surely shave off 30-50% of share holder value. A high capacity auto mag (22 caliber) on the M&P platform might be a safe bet. Kel-tecs PMR30 has a 3-5 year back log even with almost no ammo available for it. We all can speculate as to how someone else could diversify their product mix, but until WE fully understand every aspect of the business right down to tolerance levels on every production machine, we are no better than Golden acquiring a fence security company. Want in one hand and #$%$ in the other and see which one gets full faster.
As institutional ownership increases, we must get used to the lower volume. When they conclude their round of accumulation, it will appear to be drying up, but I look at it as an adjustment to float. If you cut the float in half, expect the avg volume to half. It's psychologically frustrating to investors (longs) to see volume below average, but with institutional ownership increasing steadily, daily volume averages have to decrease if the institutions are holding for the long term.
ATK would submit a publicly announced bid. We announce the sale with our votes. I doubt they would turn the conference into that kind of a circus. I'm leaning towards an awarded government contract or a behind the scenes sit down with potential buyers/investors. If Debney is seen meeting with RGR or ATK outside of this conference, it would be explosive...if he's seen talking to them at this conference, it's expected. Maybe there is something going on and they need to raise a few eye brows just a certain way to throw out a hint to persons of interest. With BlackRocks increased stake over a short period of time, somebody knows something. Having a high stake that had slowly been accumulated over a long period of time is noteable, but doubling down on that stake over a month or so is alarming (good way for longs, bad way for shorts).